Mon 4/6/2020 18:20 ET
DJIA22679.991753.167.73%TELCO164.838.745.30%GOLD1704.752.900.17%Shanghai2763.9916.580.60%
S&P 5002663.68187.267.03%BANKS303.0424.498.08%OIL26.590.291.09%BITCOIN7239.45487.216.73%
NASDAQ7913.24580.047.33%PHARM576.9523.544.08%US/EU1.080.000.00%Futures2643.623.700.14%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Spectrum Pharmaceuticals - SPPI   

Return Top | Return List | Reply Thread | Search | Add SPPI | Ignore SPPI
From: singhtelecom (Rep: 971)Date: 2018-05-11 04:15:24
Forum: Spectrum Pharmaceuticals - Thread #674008635Msg #695 - Part 1/1 (Rec: 0)
ROLONTIS® (eflapegrastim) Phase 3 data abstract to be released by American Society of Clinical Oncology (ASCO) followed by an oral presentation at Multinational Association of Supportive Care in Cancer (MASCC) in June 2018.
Message: Endorse | Reply | Privately | Bookmark | Report Abuse User singhtelecom: Reward | Watch | Ignore


TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.